AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices

by Gary Kopycinski on December 16, 2009

Gary Kopycinski Author

More in Health Care Reform:

Governor Newsom Announces Affordable CalRx® Insulin, $11 a Pen, Will Soon Be Available for Purchase October 19, 2025
How the Government Shutdown Is Hitting the Health Care System – and What the Battle Over ACA Subsidies Means October 4, 2025
Black Americans Still Suffer Worse Health. Here’s Why There’s So Little Progress. November 23, 2024

WASHINGTON–(ENEWSPF)–December 15, 2009. AARP Executive Vice President Nancy LeaMond released this statement following the Senate’s vote against a bipartisan amendment to allow for the safe and legal importation of lower-cost prescription drugs. The amendment, sponsored by Sens. Dorgan, Snowe, McCain, Grassley and Stabenow, was an AARP-designated “Key Vote.”